We are live on ! Find out more
GVI

Green Valley Investors Portfolio holdings

AUM $1.76B
1-Year Est. Return 5.64%
This Fund
S&P 500
This Quarter Est. Return
+4.04%
1 Year Est. Return
+5.64%
3 Year Est. Return
+59.43%
5 Year Est. Return
+81.11%
10 Year Est. Return
AUM
$2.05B
AUM Growth
+$20.8M
Cap. Flow
-$44.2M
Cap. Flow %
-2.15%
Top 10 Hldgs %
63.27%
Holding
30
New
1
Increased
5
Reduced
23
Closed
1

Top Buys

Rank Stock Value
1
KHC icon
Kraft Heinz
KHC
+$27.3M
2
ORLY icon
O'Reilly Automotive
ORLY
+$18.8M
3
EXAS
Exact Sciences
EXAS
+$18.2M
4
UNH icon
UnitedHealth
UNH
+$14.7M
5
NKE icon
Nike
NKE
+$9.28M

Sector Composition

Rank Sector Weight
1 Healthcare 53.6%
2 Consumer Discretionary 27.39%
3 Materials 7.31%
4 Consumer Staples 7.05%
5 Communication Services 4.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXAS
26
DELISTED
Exact Sciences
EXAS
$20.9M 1.02%
+590,684
New +$18.2M
GILD icon
27
Gilead Sciences
GILD
$162B
$16.5M 0.81%
233,555
-152,897
-40% -$10.2M
TSCO icon
28
Tractor Supply
TSCO
$17.9B
$11M 0.54%
1,017,335
-40,035
-4% -$477K
CL icon
29
Colgate-Palmolive
CL
$74.1B
$6.03M 0.29%
81,365
-3,202
-4% -$238K
AGN
30
DELISTED
Allergan plc
AGN
-208,487
Closed -$49.8M

Similar funds

Green Valley Investors's Q2 2017 Portfolio in Review

As of Q2 2017, Green Valley Investors held 30 positions worth $2.05B, up 1% from $2.03B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Green Valley Investors's Q2 2017 filing shows 1 new, 5 increased, 23 reduced and 1 closed positions. Its largest new stake was Exact Sciences: 590,684 shares worth $20.9M. The largest sale was Allergan plc, an estimated $49.8M.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, down from 55% a quarter earlier, followed by Consumer Discretionary and Materials.

  • Green Valley Investors's largest Q2 2017 buy was Exact Sciences: 590,684 shares worth $20.9M.
  • Green Valley Investors added most to Kraft Heinz in Q2 2017, an estimated $27.3M increase.
  • Green Valley Investors's biggest Q2 2017 reduction was Gilead Sciences, cutting an estimated $10.2M.
  • Green Valley Investors fully exited Allergan plc in Q2 2017, selling an estimated $49.8M.
  • Green Valley Investors's ten largest holdings make up 63% of its $2.05B portfolio in Q2 2017.
  • Green Valley Investors opened 1 new position and closed 1 in Q2 2017.
  • Green Valley Investors's portfolio value rose 1% quarter-over-quarter to $2.05B.

Based on Green Valley Investors's 13F filing for Q2 2017, filed 10 Aug 2017.